GIP/GLP-1 therapy begins with an in-depth medical intake to assess candidacy and ensure safety. Weekly injections are titrated based on individual response, with medical oversight throughout treatment. Mild side effects may include nausea, appetite changes, or fatigue—these often subside with continued use. To maximize results, patients are advised to support treatment with dietary awareness, hydration, and light activity. This service is not suitable for those with certain endocrine or GI conditions; full health history must be disclosed prior to treatment.